Mail Us

info@pharmasolutions-int.com

Contact Us

+971 4220 7991

Oxervate

The first FDA approved pharmacological therapy for the treatment of Neurotrophic Keratitis.

Share Now

Additional Information

NameOXERVATE
DescriptionThe first FDA approved  pharmacological therapy for the treatment of Neurotrophic Keratitis
Active IngredientCenegermin-bkbj
Indication
 Treatment of Neurotrophic Keratiti
Strengths0.002% 20 mcg/ ml
Regulatory StatusRegistered
Business PartnerDompe Farmaceutici
OriginItaly

Related Products

Disclaimer

Pharma Solution is the marketing agent and Distributor for the listed products for the Gulf and MENA region. The products are either registered and approved by the  respective local health authority or contracted by the MAH to supply to the end users  on a named patient basis. Some products such  as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.

[elfsight_whatsapp_chat id='1']